COVID-19 treatment Current Affairs, GK & News

WHO warns against use of ivermectin to treat Covid-19

The Health Minister of Goa recently recommended the use of “Ivermectin” to all people above the age of eighteen years. However, the World Health Organisation has warned against its use now. What did the Goa Government say? The Government of Goa recently cleared a new COVID-19 Treatment Protocol. Under the protocol, the Government had recommended ..

Month: 

Category: 

Topics: 

EpicVacCorona: Second COVID-19 Vaccine approved by Russia

The Russian Authorities have approved a new COVID-19 vaccine called “EpicVacCorona”. It is a two shot vaccine. Key Highlights EpiVacCorona is a peptide-based vaccine. Sputnik V was the first vaccine developed by Russia. Russia is to conduct the vaccine trial of EpicVacCorona on 40,000 volunteers. Clinical Trials The first phase of the vaccine is to ..

Month: 

Category: 

Topics: 

COVAXIN to use Alhydroxiquim-II to boost Immune Response

The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has sought the approval of Drugs Controller General of India to begin phase III trials. The vaccine was jointly developed by Indian Council of Medical Research and Bharat-Biotech. ..

Month: 

Category: 

Topics: 

US FDA authorizes to use blood plasma for Covid-19 treatment

The Food and Drug Administration (FDA) of America has authorized the use of blood plasma from the COVID-19 survivors. It will be used to treat the disease. As stated by the FDA, it can decrease the mortality of the patients as well as improve the health condition if it is used within the first three ..

Month: 

Category: 

Topics: 

DCGI allows use of “Itolizumab” for moderate to severe COVID-19 cases

On July 11, 2020, the Dugs Controller General of India (DCGI) granted restricted emergency use of Itolizumab for moderate to severe COVI-19 patients. Highlights Itolizumab is a monoclonal antibody that was already approved for chronic plaque psoriasis. The drug will now be used to treat COVID-19 based on clinical trials. The drug was manufactured and ..

Month: 

Category: 

Topics: